Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Pelles Sharon
23 years of experience
Clinic is certified :
Colon cancer treatment cost in Israel typically involves diagnostics like a PET/CT scan which runs $1,300 to $1,800, with primary surgical options such as a colectomy ranging from $20,500 to $33,500 or robotic surgery using the Da Vinci Robotic System costing $22,500 to $35,000. Total expenses depend on the cancer stage and hospital choice. Patients often see 20-40% savings compared to the US. Leading treatment centers are located in Tel Aviv, Jerusalem, and Haifa.
Typical Colon Cancer Treatment Costs in Israel
Bookimed Expert Insight: Early-stage patients should prioritize centers like Sourasky Medical Center for high success rates. Their surgical team, led by experts like Dr. Hagit Tulchinsky, specializes in laparoscopic resections. For advanced cases, Hadassah Medical Center offers multidisciplinary expertise in HIPEC and robotic surgery. Private options like Assuta allow patients to select specific senior surgeons for personalized care. These JCI-accredited facilities maintain specialized units for colorectal oncology and preventive genetics.
| Israel | Turkey | Austria | |
| NanoKnife | from $18,500 | from $9,500 | from $25,000 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $61,200 | from $22,500 | from $40,000 |
| Gastric polyps removal | from $2,200 | from $990 | from $5,000 |
| Da Vinci Robotic System | from $22,500 | from $9,500 | from $22,000 |
| CyberKnife | from $17,500 | from $4,750 | from $50,000 |
Dr. Pelles Sharon trained at Royal Marsden – Europe's top cancer center – specializing in gastrointestinal cancers. She directs the Digestive System Tumor Institute at Ichilov.
Prof. Ofer Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – one of Israel's top cancer hospitals.
Prof. Nadir Arber leads one of Israel's few dedicated Cancer Prevention Centers, focusing exclusively on stopping cancer before it starts.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.